Vimarsana
Biggest News Aggregation in the World

Page 20 - Caredx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caredx Today - Breaking & Trending Today

CDNA LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR - Vimarsana News

CDNA LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR

NEW YORK, May 30, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CareDx, Inc....

EQUITY ALERT: Rosen Law Firm Encourages CareDx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CDNA - Vimarsana News

EQUITY ALERT: Rosen Law Firm Encourages CareDx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CDNA

25.05.2022 - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CareDx, Inc. (NASDAQ: CDNA) between February 24, 2021 and May 5, 2022, both dates inclusive (the ...

CareDx, Inc. (NASDAQ: CDNA) SHAREHOLDER CLASS ACTION ALERT: - Vimarsana News

CareDx, Inc. (NASDAQ: CDNA) SHAREHOLDER CLASS ACTION ALERT:

Did you lose money on investments in CareDx? If so, please visit CareDx, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CareDx, Inc. (CDNA) Investors - Vimarsana News

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CareDx, Inc. (CDNA) Investors

25.05.2022 - The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) common stock between February 24, ...

CareDx, Inc.: CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation - Vimarsana News

CareDx, Inc.: CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation

CareDx Expands Transplant Portfolio in EuropeSOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company focused on the discovery, development, and